State of Alaska, Department of Revenue - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$249
-5.7%
37,797
-2.8%
0.00%0.0%
Q1 2023$264
-9.3%
38,885
-1.3%
0.00%
-25.0%
Q4 2022$291
-99.9%
39,405
+0.6%
0.00%
-20.0%
Q3 2022$386,000
-17.0%
39,159
-8.4%
0.01%
-16.7%
Q2 2022$465,000
+6.2%
42,728
+10.2%
0.01%
+20.0%
Q1 2022$438,000
-29.1%
38,758
-1.7%
0.01%
-16.7%
Q4 2021$618,000
-11.1%
39,448
-2.8%
0.01%
-14.3%
Q3 2021$695,000
-15.9%
40,588
+5.6%
0.01%
-12.5%
Q2 2021$826,000
+48.0%
38,443
+3.5%
0.01%
+33.3%
Q1 2021$558,000
-0.2%
37,156
-12.7%
0.01%0.0%
Q4 2020$559,000
+13.4%
42,566
-16.8%
0.01%0.0%
Q3 2020$493,000
-15.7%
51,136
-0.1%
0.01%
-14.3%
Q2 2020$585,000
+14.3%
51,166
+3.4%
0.01%
-12.5%
Q1 2020$512,000
-22.4%
49,476
+22.8%
0.01%
-11.1%
Q4 2019$660,000
+21.8%
40,276
-1.4%
0.01%
+28.6%
Q3 2019$542,000
+113.4%
40,866
+126.7%
0.01%
+75.0%
Q2 2019$254,000
-22.1%
18,030
+1.6%
0.00%
-33.3%
Q1 2019$326,000
-29.0%
17,742
+0.9%
0.01%
-33.3%
Q4 2018$459,000
+15.0%
17,577
+0.9%
0.01%
+28.6%
Q3 2018$399,00017,4270.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders